I-Mab ADR (IMAB) is up Wednesday morning, with the stock increasing 7.81% in pre-market trading to 1.38. IMAB's short-term technical score of 16 indicates that the stock has traded less bullishly over the last month than 84% of stocks on the market. In the Biotechnology industry, which ranks 136 out of 146 industries, IMAB ranks higher than 32% of stocks. I-Mab ADR has fallen 34.02% over the past month, closing at $1.78 on September 6. During this period of time, the stock fell as low as $1.18 and as high as $1.82. IMAB has an average analyst recommendation of Strong Buy. The company has an average price target of $16.98.
IMAB has an Overall Score of 37. Find out what this means to you and get the rest of the rankings on IMAB!